Sonoma Pharma Expands ATM Offering to $3.64M, Over 60% of Market Cap
SNOA sits 35% above its 52-week low of $0.85 on light trading volume (0.3× avg).
Summary
Sonoma Pharmaceuticals has significantly increased its at-the-market (ATM) offering capacity to $3.64 million, having already sold $574,633 in common stock under the program since September 2025. This expansion represents over 60% of the company's current market capitalization. The move comes shortly after the company's June 16th 10-K filing, which highlighted severe financial challenges, high cash burn, and substantial intercompany debt, underscoring an urgent need for capital. This highly dilutive offering will help fund operations but will significantly impact existing shareholders.
At the time of this announcement, SNOA was trading at $1.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $0.85 to $6.92. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.